Indicate by check mark if the registrant is a well‑known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ☐ No ☒
Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes ☐ No ☒
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☐ No ☒
Indicate by check mark whether the registrant has submitted electronically on its corporate Web site, if any, every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S‑T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐
Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S‑K (§ 229.405 of this chapter) is not contained herein, and will not be contained, to the best of registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10‑K or any amendment to this Form 10‑K. ☒
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b‑2 of the Exchange Act.
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☒
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b‑2 of the Exchange Act). Yes ☐ No ☒
The aggregate market value of voting and non‑voting common equity held by non‑affiliates of the registrant as of June 28, 2019 was approximately $22,211,556 (based on a closing sale price of $1.39 per share as reported for the NASDAQ Global Select Market on June 28, 2019). For purposes of this calculation, shares of common stock held by officers, directors and their affiliated holders and shares of common stock held by persons who hold more than 10% of the outstanding common stock of the registrant have been excluded from this calculation because such persons may be deemed to be affiliates. This determination of executive officer or affiliate status is not necessarily a conclusive determination for other purposes.
As of February 20, 2020, 21,217,537 shares of the registrant’s Common Stock, $ 0.001 par value, were outstanding.
Notes to Consolidated Financial Statements
December 31, 2019 and 2018
Note 1 - Nature of Business
The Company was organized on January 17, 2007 (Date of Inception) under the laws of the State of Nevada, as DBL Senior Care, Inc. and subsequently changed its name to DLT Resolution Inc on December 4, 2017.
DLT Resolution Inc. (“DLT”) currently operates in three high-tech industry segments: Blockchain Applications; Telecommunications; and Data Services which includes Image Capture, Data Collection, Data Phone Center Services, and Payment Processing. The Company completed its acquisition of 1922861 Ontario Inc. (“Ontario”) as on April 12, 2018. See Note 7 – Acquisition of 1922861 Ontario Inc. Both acquisitions were considered business combinations under ASC 805 “Business Combinations”.
The Company offers secure data management, Information Technology (IT) and other telecommunications services in Canada and the United States. Through its RecordsBank.org portal it operates a Health Information Exchange. DLT Resolution also operates a Health Information Exchange providing the ability to request and retrieve medical information and records while meeting all of today’s Security & Compliance demands for HIPAA, PIPEDA and PHIPA. The Company is preparing to launch a Distributed Ledger Technology “Blockchain” version of the service placing electronic health records on this secure platform. The Company has finished making the “Blockchain” but has yet to launch the initiative yet. The Company expects to launch this initiative during the third calendar quarter of 2019.
Previously, the Company’s business plan and objective through late 2016 was to focus on hemorrhoid medical procedures for which it entered into a license agreement to open hemorrhoid treatment centers and promote the Ultroid Hemorrhoid System globally. However, the Company under new Management, ceased that plan.
The Company has its distributed ledger technology architecture in place for electronic health records, it has opted to defer its plans for a utility token sale. A Utility Token allows a purchaser to exchange tokens for use of a utility, in this case using Records Bank in the capacity of any prospective stakeholder involved in the exchange of electronic heath records. Management’s decision to defer the sale is based on its judgement of market conditions for said sale. This will be done further down the road when the funds are available to produce the utility token sale.
DLT operates in Canada through its wholly owned subsidiary DLT Resolution Corp., its wholly owned subsidiary DLT Data Services Ltd. formed in December 2018. Additionally, on January 14, 2019, the Company sold 70 of the 80 shares purchased in A.J.D. Data Services Ltd and then wrote off the entire purchase of the company reflected in the financials.
Note 2 - Significant Accounting Policies
Estimates
The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.
Cash
For the Statements of Cash Flows, all highly liquid investments with maturity of three months or less are considered to be cash equivalents.
Income taxes
Income taxes are provided for using the liability method of accounting in accordance with FASB ASC Topic 740 (formally SFAS No. 109 “Accounting for Income Taxes”). A deferred tax asset or liability is recorded for all temporary differences between financial and tax reporting. Temporary differences are the differences between the reported amounts of assets and liabilities and their tax basis. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. Deferred tax assets and liabilities are adjusted for the effect of changes in tax laws and rates on the date of enactment.
At December 31, 2019, there were no uncertain tax positions that require accrual.
DLT RESOLUTION INC.
(FORMERLY HEMCARE HEALTH SERVICES INC.)
Notes to Consolidated Financial Statements
December 31, 2018 and 2017
Accounts Receivable
Accounts receivable balances are established for amounts owed to the Company from its customers from the sales of services and products. The Company closely monitors the collectability of outstanding accounts receivable and provide an allowance for doubtful accounts based on estimated collections of outstanding amounts.
Revenue Recognition
During the year ended December 31, 2019, the Company generated revenues from the sale of general information technology services focused on telephone system set up. The Company generated revenues of $463,325 and $227,343 during the years ended December 31, 2019 and 2018, respectively. The increase in revenue is the result of the Company’s acquisitions of 1922861 Ontario Inc.
Property and equipment
Property and equipment are stated at cost less accumulated depreciation. The Company provides for depreciation using the straight-line method over the estimated useful lives of the related assets, which range from three to five years.Maintenance and repair costs are expensed as they are incurred while renewals and improvements which extend the useful life of an asset are capitalized. At the time of retirement or disposal of property and equipment, the cost and related accumulated depreciation are removed from the accounts and any resulting gain or loss is reflected in the consolidated results of operations.
Intangible Assets
Intangible assets primarily consist of customer relationships, software, non-compete agreements and domain names. The Company amortizes, to cost of revenue and operating expenses, these definite‑lived intangible assets on a straight‑line basis over the life of the assets which range from five to seven years.
Impairment of Long‑Lived Assets and Goodwill
The carrying value of long‑lived assets is reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset or asset group may not be recoverable. An impairment loss is recognized when the carrying amount of an asset exceeds the estimated undiscounted future cash flows expected to result from the use of the asset and its eventual disposition. The amount of the impairment loss to be recorded is calculated by the excess of the asset’s carrying value over its fair value. Fair value is generally determined using a discounted cash flow analysis.
The Company tests goodwill for impairment annually as of December 31, or whenever events or changes in circumstances indicate that goodwill may be impaired. The Company initially assesses qualitative factors to determine whether the existence of events or circumstances leads to a determination that it is more likely than not that the fair value of a reporting unit is less than its carrying amount. If, after assessing the totality of events or circumstances, the Company determines it is more likely than not that the fair value of a reporting unit is less than its carrying amount, then the Company compares the reporting unit’s carrying amount to its fair value. If the reporting unit’s carrying amount exceeds its fair value, an impairment charge is recorded based on that difference.
There was no impairment of long-lived assets or goodwill during the periods presented.
Convertible debt
The Company records beneficial conversion features related to the issuance of convertible debts that have conversion features at fixed or adjustable rates that are less than the Company’s stock prices on the respective issuance dates. The beneficial conversion features for the convertible instruments are recognized and measured by allocating a portion of the proceeds as an increase in additional paid-in capital and as a reduction to the carrying amount of the convertible instruments equal to the intrinsic value of the conversion features based on the difference between the effective conversion rates and the Company’s stock prices on the issuance dates. The beneficial conversion features are accreted by recording additional non-cash interest expense over the expected life of the convertible notes.
Software Development Costs and Amortization
The Company capitalizes software development costs in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 985-20. Software development costs are capitalized after technological feasibility is established. Once the software products become available for general release to the public, the Company amortizes such costs over the related product’s estimated economic useful life to general and administrative expenses.
Reclassification of Prior Year Presentation
Certain prior year amounts have been reclassified for consistency with the current period presentation. These reclassification had no effect on the reported results of operation.
DLT RESOLUTION INC.
(FORMERLY HEMCARE HEALTH SERVICES INC.)
Notes to Consolidated Financial Statements
December 31, 2018 and 2017
Note 2 - Significant Accounting Policies (continued)
Share Based Expenses
The Company complies with FASB ASC Topic 718 Compensation—Stock Compensation, which establishes standards for the accounting for transactions in which an entity exchanges its equity instruments for goods or services. It also addresses transactions in which an entity incurs liabilities in exchange for goods or services that is based on the fair value of the entity’s equity instruments or that may be settled by the issuance of those equity instruments. FASB ASC Topic 718 primarily focuses on accounting for transactions in which an entity obtains employee services in share-based payment transactions. This statement requires a public entity to expense the cost of employee services received in exchange for an award of equity instruments. This statement also provides guidance on valuing and expensing these awards, as well as disclosure requirements of these equity arrangements.
Net Income (Loss) Per Share
Net loss per share is calculated in accordance with FASB ASC topic 260.Basic earnings (loss) per share is computed by dividing net income, or loss, by the weighted average number of shares of common stock outstanding for the period. Diluted earnings (loss) per share is computed by dividing net income, or loss, by the weighted average number of shares of common stock outstanding for the period, assuming conversion or exercise of all potentially dilutive securities outstanding during each reporting period presented. Potentially dilutive securities are not presented or used in the computation of diluted loss per share on the statement of operations for periods when the Company incurs net losses, as their effect would be anti-dilutive.
As of December 31, 2019, and December 31, 2018, the Company had 0 and 0 shares, respectively, of Series A Preferred Stock issued and outstanding, which were convertible into 0 and 0 shares, respectively, of the Company’s common stock. Also, as of December 31, 2019 and December 31, 2018, the Company had 64,000 shares of Series B Convertible Preferred Stock issued and outstanding, which were convertible into 12,800 shares of the Company’s common stock. As of December 31, 2019 there is a potential earn out of an additional 500,000 restricted common shares of stock from the acquisition of 1922861 Ontario Inc (see Note 7 – Acquisition of 1922861 Ontario Inc).
Principals of Consolidation
The consolidated financial statements represent the results of DLT Resolution, Inc.; its wholly owned subsidiaries, DLT Resolution Corp. and DLT Data Services; and the assets, processes, and results therefrom of 1922861 Ontario Inc. Note 7 – Acquisition of 1922861 Ontario Inc.) All intercompany transactions and balances have been eliminated.
Foreign Currency Translation
The functional currency of the Company’s subsidiaries in Canada is the Canadian Dollar. The subsidiaries’ assets and liabilities have been translated to U.S. dollars using exchange rates of 0.771486 and 0.732902 in effect at the balance sheet dates of December 31, 2019 and December 31, 2018, respectively. Statements of operations amounts have been translated using the annual weighted average exchange rates of 0.753670 for the year ended December 31, 2019. Resulting gains or losses from translating foreign currency financial statements are recorded as other comprehensive income (loss). Foreign currency transaction gains and losses resulting from exchange rate fluctuations on transactions denominated in a currency other than the local currency are included in other income (expense). There was $5,362 currency transaction gains recognized during the periods presented.
Fair Value of Financial Instruments
Fair value of certain of the Company’s financial instruments including cash, prepaid expenses, accounts payable, accrued expenses, notes payable, and other accrued liabilities approximate cost because of their short maturities. The Company measures and reports fair value in accordance with ASC 820, “Fair Value Measurements and Disclosure” defines fair value, establishes a framework for measuring fair value in accordance with generally accepted accounting principles and expands disclosures about fair value investments.
Fair value, as defined in ASC 820, is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The fair value of an asset should reflect its highest and best use by market participants, principal (or most advantageous) markets, and an in-use or an in-exchange valuation premise. The fair value of a liability should reflect the risk of nonperformance, which includes, among other things, the Company’s credit risk.
DLT RESOLUTION INC.
(FORMERLY HEMCARE HEALTH SERVICES INC.)
Notes to Consolidated Financial Statements
December 31, 2018 and 2017
Valuation techniques are generally classified into three categories: the market approach; the income approach; and the cost approach. The selection and application of one or more of the techniques may require significant judgment and are primarily dependent upon the characteristics of the asset or liability, and the quality and availability of inputs. Valuation techniques used to measure fair value under ASC 820 must maximize the use of observable inputs and minimize the use of unobservable inputs. ASC 820 also provides fair value hierarchy for inputs and resulting measurement as follows:
Level 1: Quoted prices (unadjusted) in active markets that are accessible at the measurement date for identical assets or liabilities.
Level 2: Quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; inputs other than quoted prices that are observable for the asset or liability; and inputs that are derived principally from or corroborated by observable market data for substantially the full term of the assets or liabilities; and
Level 3: Unobservable inputs for the asset or liability that are supported by little or no market activity, and that are significant to the fair values.
Fair value measurements are required to be disclosed by the Level within the fair value hierarchy in which the fair value measurements in their entirety fall. Fair value measurements using significant unobservable inputs (in Level 3 measurements) are subject to expanded disclosure requirements including a reconciliation of the beginning and ending balances, separately presenting changes during the period attributable to the following: (i) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings, and a description of where those gains or losses included in earning are reported in the statement of income.
Recently Issued Accounting Pronouncements
In August 2018, the SEC adopted the final rule under SEC Release No. 33-10532, “Disclosure Update and Simplification,” amending certain disclosure requirements that were redundant, duplicative, overlapping, outdated or superseded. In addition, the amendments expanded the disclosure requirements on the analysis of stockholders’ equity for interim financial statements. Under the amendments, an analysis of changes in each caption of stockholders’ equity presented in the balance sheet must be provided in a note or separate statement. This analysis should present a reconciliation of the beginning balance to the ending balance of each period for which a statement of comprehensive income is required to be filed. This final rule was effective as of November 5, 2018. The adoption of this final rule did not have a material impact on the financial statements.
In June 2018, the FASB issued ASU 2018-07, “Compensation – Stock Compensation (Topic 718): Improvements to Nonemployee Share-Based Payment Accounting,” which expands the scope of Topic 718 to include all share-based payment transactions for acquiring goods and services from non-employees. This pronouncement is effective for fiscal years, and for interim periods within those fiscal years, beginning after December 15, 2018, with early adoption permitted. The Company elected to early-adopt this standard in the current period; the adoption of this standard did not impact the financial statements.
In November 2016, the FASB issued ASU 2016-18, “Statement of Cash Flows (Topic 230): Restricted Cash,” which provides amendments to current guidance to address the classifications and presentation of changes in restricted cash in the statement of cash flows. The effective date for the standard is for fiscal years beginning after December 15, 2017. The Company adopted the standard effective January 1, 2018; the adoption of this standard did not have a material impact on the financial statements.
In October 2016, the FASB issued ASU 2016-16, “Income Taxes (Topic 740): Intra-Entity Transfers of Assets Other Than Inventory.” The amendments in this update will require recognition of current and deferred income taxes resulting from an intra-entity transfer of an asset other than inventory when the transfer occurs. This update is effective for annual and interim periods beginning after December 15, 2017. The Company adopted the standard effective January 1, 2018; the adoption of this standard did not have a material impact on the financial statements.
In February 2018, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) 2018-02, Income Statement Reporting, Comprehensive Income (Topic 220). Effective for all entities for fiscal years beginning after December 15, 2018, and interim periods within those fiscal years. Early adoption of the amendments in this Update is permitted, including adoption in any interim period, (1) for public business entities for reporting periods for which financial statements have not yet been issued and (2) for all other entities for reporting periods for which financial statements have not yet been made available for issuance. The amendments in this Update should be applied either in the period of adoption or retrospectively to each period (or periods) in which the effect of the change in the U.S. federal corporate income tax rate in the Tax Cuts and Jobs Act is recognized. The adoption of this guidance by the Company is not expected to have a material impact on our condensed financial statements and related disclosures.
Management believes recently issued accounting pronouncements will have no impact on the financial statements of the Company.
DLT RESOLUTION, INC.
(FORMERLY HEMCARE HEALTH SERVICES INC.)
Notes to Consolidated Financial Statements
December 31, 2018 and 2017
Note 3 - Going concern
The Company’s consolidated financial statements are prepared in accordance with generally accepted accounting principles applicable to a going concern. This contemplates the realization of assets and the liquidation of liabilities in the normal course of business. Currently, the Company has limited cash and accumulated losses of $4,632,348. These factors raise substantial doubt about the Company’s ability to continue as a going concern. The Company will be dependent upon the raising of additional capital through placement of our common stock in order to implement its business plan, or merge with an operating company. There can be no assurance that the Company will be successful in either situation in order to continue as a going concern. The officers and directors have committed to advancing certain operating costs of the Company.
Note 4 - Related Party Transactions
No salaries were paid to directors or executives during the periods ended December 31, 2019 or 2018. All related party intercompany transactions have been eliminated.
During the year ended December 31, 2019, the Company had payments of $3,153 to related parties and had proceeds on outstanding payables from other related parties of $129,254. The related party payables and receivables to and from the Company are unsecured and due on demand. There were $20,880 and $17,713 due to related parties as of December 31, 2019 and December 31, 2018, respectively. During the year ended December 31, 2019, the Company also made payments for services rendered by related parties totaling $25,000, resulting in balances owed for such services of $15,000 and $40,000 at December 31, 2019 and December 31, 2018.
Interest payable, related party had a balance of $34,190 and $26,875 for the years ended December 31, 2019 and 2018 respectively. The interest payable relates to a current notes payable, related party and accrues interest at 9% per annum. $7,315 of interest expense was accrued for the year ended December 31, 2019.
Current notes payable, related party had a balance of $81,500 and $81,500 for the years ended December 31, 2018 and 2017 respectively. This balance consists of one note payable to one related company and accrues interest at 9% per annum. No principal payments were made in 2018.
Note 5 - Stockholders’ Equity
Series A Convertible Preferred Stock
The Company is authorized to issue up to 5,000,000 shares of Series A Convertible Preferred Stock. The Series A Convertible Preferred Stock can be converted to common shares at the option of the holder at a rate of $1 per share.
During the year ended December 31, 2018, the Company accepted the conversion of 25,000 shares of Series A Convertible Preferred Stock in exchange for 25,000 shares of common stock.
There were 0 and 0 shares of series A convertible preferred stock issued and outstanding as of December 31, 2019 and December 31, 2018, respectively.
Series B Convertible Preferred Stock
The Company is authorized to issue up to 500,000 shares of Series B Convertible Preferred Stock. The Series B Convertible Preferred Stock can be converted to common shares at the option of the holder at a rate of $0.20 per share.
There were 64,000 shares of series B convertible preferred stock issued and outstanding as of December 31, 2019 and December 31, 2018.
DLT RESOLUTION INC.
(FORMERLY HEMCARE HEALTH SERVICES INC.)
Notes to Consolidated Financial Statements
December 31, 2018 and 2017
Common Stock
The authorized common stock of the Company consists of 275,000,000 shares and carries a par value of $0.001. During the year ended December 31, 2014, the Company bought back 38,000 post-split shares of common stock into treasury from a former officer for $100. The shares are being carried as treasury shares as reflected on the balance sheet.
During the year ended December 31, 2017, the Company issued a $5,000 note payable and $200 related party payable for a total of 3,777,000 outstanding common shares which are carried as treasury stock. There were 3,815,000 common shares held as treasury stock as of December 31, 2018 and December 31, 2017, respectively.
During the year ended December 31, 2018, the Company issued 745,778 common shares for cash proceeds of $236,000; 1,575,000 common shares valued at $360,729 for the acquisition of A.J.D. Data Services; 1,000,000 common shares valued at $417,815 for the acquisition of 1922861 Ontario Inc; 25,000 common shares for the conversion of 25,000 shares of Series A Convertible Preferred Stock and 63,888 common shares for rounding differences from the effect of a reverse stock split effected during the year ended December 31, 2017. Since then the company has written off the purchase of AJD Data Services along with everything involved with the Company.
There were 24,395,037 and 24,982,537 common shares issued and 21,167,537 and 21,167,537 outstanding at December 31, 2019 and December 31, 2018, respectively.
There were 650,000 shares that were retired in the 2019 calendar year.
Note 6 – Notes Payable
Related Party
During the year ended December 31, 2015, the Company entered into a note payable with a related party as a settlement for payment of consulting services provided valued at $350,000. The note carries interest of 9% compounded annually and was due on November 19, 2016. During the year ended December 31, 2016, the Company issued 50,000 shares of series A convertible preferred stock as repayment of $31,500 of accrued interest and $18,500 of outstanding principal. Additionally, on January 31, 2017, the Company issued 1,250,000 shares of common stock as repayment of $250,000 of principal. There was $81,500 and $81,500 of principal and $34,190 and $26,875 of accrued interest due as of December 31, 2019 and December 31, 2018.
Non – Related Party
On August 1, 2017, the Company entered into a note payable with an unrelated party to purchase common stock held by the unrelated party. The note was due on July 1, 2019 and bears no interest. There was $5,000 and $5,000 due as of December 31, 2019 and December 31, 2018.
Note 7 – Convertible Notes Payable
On May 22, 2017, the Company entered into a convertible note payable with an unrelated party for $4,900 which was paid to a vendor on the Company’s behalf. The note carried interest at 10% per annum, was due on demand and was convertible at the option of the holder into common stock of the Company at a rate equal to the lesser of a 50% discount from the last trade price of the stock or $0.01 per share. There was $0 and $4,900 of principal and $0 and $3,048 of accrued interest due as of December 31, 2018 and December 31, 2017, respectively, which is included in “accounts payable and accrued liabilities” on the balance sheet. See Note 8 – Derivative Liability for explanation of related derivative liability derived from variable conversion rate. This note was settled in full in May 2018 against the payment of $5,390 which included an interest payment of $490 and $4,900 of principal payment. The outstanding liability of $2,679 including $120 of current year’s interest expense and $2,559 of accrued interest was forgiven by the holder.
DLT RESOLUTION INC.
(FORMERLY HEMCARE HEALTH SERVICES INC.)
Notes to Consolidated Financial Statements
December 31, 2018 and 2017
Note 8 – Derivative Liability
As of December 31, 2019 and December 31, 2018, Company had a derivative liability balance of $0 and $0 on the balance sheets and recorded loss of $0 and $2,427 for the years ended December 31, 2019 and 2018, respectively. The derivative liability activity comes from convertible notes payable as follows:
As discussed in Note 7 – Convertible Notes Payable, on May 22, 2017 the Company issued a $4,900 Convertible Promissory Note to an unrelated party that is due on demand. The note bears interest at a rate of 10% per annum and can be convertible into the Company’s common shares 90 days after issuance, at the holder’s option, at the conversion rate equal to the lesser of a 50% discount from the last trade prior to conversion or $0.01. The Company analyzed the conversion feature of the agreement for derivative accounting consideration under ASC 815-15 “Derivatives and Hedging” and determined that the embedded conversion features should be classified as a derivative because the exercise price of these convertible notes are subject to a variable conversion rate. In accordance with ASC 815, the Company has bifurcated the conversion feature of the note and recorded a derivative liability.
The Company carries its derivative liability on the balance sheet at fair value. The derivative liability is marked-to-market each measurement period and any unrealized change in fair value is recorded as a component of the income statement and the associated fair value carrying amount on the balance sheet is adjusted by the change. The Company fair-values the embedded derivative using the Black-Scholes option pricing model. The fair value of the derivative at the issuance date of this note was $5,348 which was recorded as a derivative liability on the balance sheet. The Company recorded a debt discount of $4,900 which was equal to the face value of the convertible note, and immediately expensed $448. Although the note was due on demand, upon issuance the Company estimated a six-month repayment period, over which they amortized the debt discount in full. As such, the Company recorded $4,900 in amortization expense during the year ended December 31, 2017.
The convertible note was repaid in full on May 22, 2018, on which date the Company determined the derivative’s fair value to be $22,775, which was written back during the year and resulted in a $2,427 net loss from change in fair value for the six months ended June 30, 2018. The fair value of the embedded derivatives for the notes was determined using a Black Scholes valuation model based on the following assumptions: (1) expected volatility of 338%, (2) risk-free interest rate of 2.13%, and (3) expected life of 0.50 of a year.
There is no derivative liability outstanding as of December 31, 2019.
Note 9 – Acquisition of A.J.D. Data Services
On January 21, 2018, the Company entered into and closed the transactions contemplated by the definitive stock purchase agreement and plan of re-organization by and among the Company, A.J.D. Data Services Ltd., a limited liability company organized under the laws of Ontario (“A.J.D.”), the stockholders of A.J.D. and other parties signatory thereto to acquire 80 shares, representing 80% of the issued and outstanding capital stock of A.J.D. for 525,000 restricted common shares of the Company valued at $120,195. The first milestone earnout was met on September 21, 2018 resulting in additional 1,050,000 restricted common shares of the Company valued at $240,390. A.J.D. is focused on document imaging, telemarketing, data entry, document management and all other back-end functions. The acquisition is intended to be part of a tax-free share-for-share exchange which will see DLT Resolution issuing restricted common shares on closing and an additional 2,625,000 restricted common shares upon meeting the following milestones:
|
|
·
|
1,050,000 Shares upon A.J.D Data Services reaching $1,000,000 in cumulated gross sales
|
|
|
|
|
|
|
·
|
525,000 Shares upon A.J.D Data Services reaching $1,500,000 in cumulated gross sales with $100,000 in pre-tax earnings
|
|
|
|
|
|
|
·
|
525,000 Shares upon A.J.D Data Services reaching $2,000,000 in cumulated gross sales with $150,000 in pre-tax earnings
|
|
|
|
|
|
|
·
|
525,000 Shares upon A.J.D Data Services reaching $2,500,000 in cumulated gross sales with $200,000 in pre-tax earnings
|
DLT RESOLUTION INC.
(FORMERLY HEMCARE HEALTH SERVICES INC.)
Notes to Consolidated Financial Statements
December 31, 2018 and 2017
The Company applied the acquisition method to the business combination and valued each of the assets acquired (cash, accounts receivable, equipment, customer relationships, software, domain names and non-compete agreements) and liabilities assumed (accounts payable and related party payable) at fair value as of the acquisition date. The carrying values of cash, accounts receivable, accounts payable and related party payable were deemed to be fair value as of the acquisition date. The Company determined the fair value of the equipment to be historical net book value. The preliminary allocation of the purchase price was based on estimates of the fair value of the assets and liabilities assumed based on provisional amounts. However, the allocation of the excess purchase price and the amounts allocated to intangible assets are now as per the valuation of assets and liabilities performed by an independent valuer. Under the purchase agreement, the Company issued 525,000 shares of common stock valued at $120,195 and committed to issue an additional 3,675,000 shares of common stock at certain milestones which was determined to have a fair value of $841,366 in exchange for 80% interest. The estimated fair value of the common stock to be issued of $600,880 was eliminated against the investment as assets and liabilities held for sale.
|
ASSETS ACQUIRED
|
|
|
|
|
Cash
|
|
$
|
302
|
|
|
Accounts receivable
|
|
|
37,590
|
|
|
Equipment
|
|
|
22,743
|
|
|
Customer relationships
|
|
|
201,759
|
|
|
Software
|
|
|
156,124
|
|
|
Non-compete agreement
|
|
|
172,136
|
|
|
Domain name
|
|
|
6,405
|
|
|
Goodwill
|
|
|
654,389
|
|
|
TOTAL ASSETS ACQUIRED
|
|
$
|
1,251,448
|
|
|
|
|
|
|
|
|
LIABILITIES ASSUMED
|
|
|
|
|
|
Accounts payable
|
|
|
49,380
|
|
|
Related party payable
|
|
|
317
|
|
|
TOTAL LIABILITIES ASSUMED
|
|
|
49,697
|
|
|
|
|
|
|
|
|
Non-controlling interest
|
|
|
240,190
|
|
|
NET ASSETS ACQUIRED
|
|
$
|
961,561
|
|
The intangible assets acquired will be amortized over 5 years.
The non-controlling interest was valued using an enterprise value approach whereby the total value of all net assets of A.J.D. were valued with the non-controlling interest representing the minority interest percentage of the net assets as of the date of acquisition. The non-controlling interest was determined to have a fair value of $240,190 as of the date of acquisition.
From the period of acquisition on January 21, 2018 to December 31, 2018, A.J.D. generated total revenues of $554, 351. However, revenues of $37,085 earned were not correct and we had to accrue an allowance for bad debts on a large portion of these monies due to management of A.J.D. not being forthcoming in their accounting records. See note on discontinued operations for further information regarding the allowance for doubtful accounts.
Note 10 – Acquisition of 1922861 Ontario Inc
Acquisition of Operating Assets
On April 12, 2018, the Company entered into and closed the transactions contemplated by the definitive asset purchase agreement and plan of re-organization by and among the Company, 1922861 Ontario Inc. a corporation organized under the laws of Ontario (“ 1922861 Ontario Inc. ”), the stockholders of 1922861 Ontario Inc. and other parties signatory thereto to acquire all the operating assets of 1922861 Ontario Inc. for 500,000 restricted common shares of DLT Resolution valued at $212,520, and a payment of CAD $19,200 to 1922861 Ontario’s supplier. On September 21, 2018 the 1922861 Ontario Inc acquisition reached the first milestone and received another 500,000 restricted commons shares of DLT Resolution valued at $205,295. The acquisition is considered a business combination for accounting purposes under ASC 805, and resulted in the integration of 1922861 Ontario Inc.’s operating assets and processes into the Company’s Canadian subsidiary DLT Resolution Corp.
DLT RESOLUTION INC.
(FORMERLY HEMCARE HEALTH SERVICES INC.)
Notes to Consolidated Financial Statements
December 31, 2018 and 2017
In addition to the consideration on closing, an additional 500,000 restricted common shares may potentially be issued upon meeting the following milestone:
|
·
|
500,000 shares will be issued upon the acquired base generating CAD $500,000 in cumulated gross sales with a 10% pre-tax profit.
|
The Company has allotted 24 months to achieve this milestone. There is full acceleration to allow for full vesting as quickly as the cumulative sales milestones are reached. Share issuances will be issued under reliance of appropriate exemptions from registration with the Securities & Exchange Commission and will contain substantial resale restrictions.
The Company applied the acquisition method to the business combination and valued each of the assets acquired (cash, accounts receivable, equipment, customer relationships, software, domain names and non-compete agreements) and liabilities assumed (accounts payable and related party payable) at fair value as of the acquisition date. The carrying values of cash, accounts receivable, accounts payable and related party payable were deemed to be fair value as of the acquisition date. The Company determined the fair value of the equipment to be historical net book value. The preliminary allocation of the purchase price was based on estimates of the fair value of the assets and liabilities assumed based on provisional amounts. However, the allocation of excess purchase and the amounts allocated to intangible assets are now as per valuation of assets and liabilities performed by independent valuer. Under the purchase agreement, the Company issued 1,000,000 shares of common stock valued at $417,815 and committed to issue an additions 500,000 shares of common stock at certain milestones which was determined to have a fair value of $685,000 with mark to market pricing of DLT stock price as of December 31, 2019. Listed stock price was $1.37 on December 31st to determine value. The estimated fair value of the common stock to be issued of $685,000 is shown as an “other long-term liability” on the face of the balance sheet. The following table shows the estimated fair values of the assets acquired and liabilities assumed at the date of acquisition:
|
ASSETS ACQUIRED
|
|
|
|
|
|
|
$
|
|
|
|
Accounts receivable
|
|
|
18,663
|
|
|
Customer list
|
|
|
103,255
|
|
|
Developed technology
|
|
|
321,679
|
|
|
Domain and trade name
|
|
|
3,971
|
|
|
Non-compete
|
|
|
37,330
|
|
|
Goodwill
|
|
|
169,896
|
|
|
TOTAL ASSETS ACQUIRED
|
|
$
|
654,794
|
|
|
|
|
|
|
|
|
LIABILITIES ASSUMED
|
|
|
|
|
|
Accounts payable
|
|
|
22,197
|
|
|
HST payable
|
|
|
2,147
|
|
|
TOTAL LIABILITIES ASSUMED
|
|
|
24,344
|
|
|
|
|
|
|
|
|
NET ASSETS ACQUIRED
|
|
$
|
630,450
|
|
DLT RESOLUTION INC.
(FORMERLY HEMCARE HEALTH SERVICES INC.)
Notes to Consolidated Financial Statements
December 31, 2019 and 2018
Note 11 – Pro-Forma Financials for Acquisitions in 2018 (combined 1922861 Ontario Inc and A.J.D. Data Services)
In accordance with ASC 805-10-50, the Company is providing the following unaudited pro-forma to present a summary of the combined results of the Company’s consolidated operations with all acquisitions. as if the acquisitions had been completed as of the beginning of the reporting period. Adjustments were made to eliminate any inter-company transactions in the periods presented.
|
DLT RESOLUTION, INC.
|
|
|
Unaudited Pro-Forma Consolidated Statements of Operations
|
|
|
|
|
|
|
|
|
|
|
|
|
Year ended December 31,
|
|
|
|
|
2018
|
|
|
2017
|
|
|
Revenue
|
|
$
|
953,430
|
|
|
$
|
2,423
|
|
|
Cost of revenue
|
|
|
144,210
|
|
|
|
379
|
|
|
Gross margin
|
|
|
809,220
|
|
|
|
2,044
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating expenses
|
|
|
|
|
|
|
|
|
|
General and administrative
|
|
|
968,845
|
|
|
|
14,369
|
|
|
Professional fees
|
|
|
235,328
|
|
|
|
24,351
|
|
|
Total operating expenses
|
|
|
1,204,172
|
|
|
|
38,720
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) from operations
|
|
|
(394,951
|
)
|
|
|
(36,676
|
)
|
|
|
|
|
|
|
|
|
|
|
|
Other income (expense)
|
|
|
|
|
|
|
|
|
|
Other income
|
|
|
32,204
|
|
|
|
26,306
|
|
|
Gain/(loss) on change in fair market value of derivative liability
|
|
|
(2,427
|
)
|
|
|
(14,980
|
)
|
|
Foreign exchange gain/(loss)
|
|
|
(3,992
|
)
|
|
|
-
|
|
|
Interest expense
|
|
|
(4,767
|
)
|
|
|
(19,337
|
)
|
|
Total other income (expense)
|
|
|
21,018
|
|
|
|
(8,011
|
)
|
|
|
|
|
|
|
|
|
|
|
|
Net loss
|
|
$
|
(373,933
|
)
|
|
$
|
(44,687
|
)
|
|
|
|
|
|
|
|
|
|
|
|
Preferred stock dividends declared
|
|
$
|
-
|
|
|
$
|
(1,249
|
)
|
|
Net income (loss)
|
|
$
|
(373,933
|
)
|
|
$
|
(45,936
|
)
|
|
|
|
|
|
|
|
|
|
|
|
Net loss per common share, basic and diluted
|
|
$
|
(0.02
|
)
|
|
$
|
(0.00
|
)
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average basic shares outstanding
|
|
|
19,263,408
|
|
|
|
18,571,882
|
|
|
Weighted average diluted shares outstanding
|
|
|
19,263,408
|
|
|
|
18,571,882
|
|
|
|
|
|
|
|
|
|
|
|
|
See accompanying notes to consolidated financial statements.
|
DLT RESOLUTION INC.
(FORMERLY HEMCARE HEALTH SERVICES INC.)
Notes to Consolidated Financial Statements
December 31, 2019 and 2018
Note 12 - Income Taxes
We did not provide any current or deferred U.S. federal income tax provision or benefit for any of the periods presented because we have experienced operating losses since inception. Pursuant to FASB ASC Topic 740, when it is more likely than not that a tax asset cannot be realized through future income, the Company must provide an allowance for this future tax benefit. We provided a full valuation allowance on the net deferred tax asset, consisting of net operating loss carry-forwards, because management has determined that it is more likely than not that we will not earn income sufficient to realize the deferred tax assets during the carry-forward period. The Company records estimated losses from interest and penalties arising from taxes remitted late as well as unrecognized tax benefits as they are incurred as general and administrative expenses. The Company did not have accrued interest or penalties related to income taxes as of December 31, 2019 or 2018. The Company has not filed the 2018 tax returns with the IRS as of the date of this filing.
The sources and tax effects of the temporary differences for the periods presented are as follows (rounded to the nearest thousand):
|
|
|
December 31,
2019
|
|
|
December 31
2018
|
|
|
Net operating loss carry forward
|
|
$
|
2,201,000
|
|
|
$
|
1,172,000
|
|
|
Applicable Canadian Federal and Provincial tax rates
|
|
|
26.5
|
%
|
|
|
26.5
|
%
|
|
Deferred tax asset related to net operating losses
|
|
|
585,000
|
|
|
|
317,000
|
|
|
Deferred tax asset relating to debt discounts and derivative liability (at 26.55)
|
|
|
-
|
|
|
|
(5,000
|
)
|
|
Valuation allowance
|
|
|
(585,000
|
)
|
|
|
(312,000
|
)
|
|
Net deferred tax asset
|
|
$
|
-
|
|
|
$
|
-
|
|
A reconciliation of income taxes computed at the United States federal statutory rate of 21% and 35% to the income tax recorded is as follows:
|
|
|
December 31,
2019 (21%)
|
|
|
December 31,
2018 (35%)
|
|
|
Tax benefit at United States Federal statutory rate
|
|
$
|
110,000
|
|
|
$
|
27,000
|
|
|
Differences in U.S. and Canadian tax rates on provision
|
|
|
29,000
|
|
|
|
7,000
|
|
|
Increase in valuation allowance
|
|
|
(139,000
|
)
|
|
|
(34,000
|
)
|
|
Income tax provision
|
|
$
|
-
|
|
|
$
|
-
|
|
The Company did not pay any income taxes during the years ended December 31, 2019 or 2018, or since inception.
The net federal operating loss carry forward will begin to expire in 2026. This carry forward may be limited upon the consummation of a business combination under IRC Section 381. Tax years commencing at inception remain open for examination by the IRS, where applicable.
Effective January 1, 2018, the U.S. Congress enacted the “Tax Jobs and Cuts Act” which, among other things, reduced the maximum corporate tax rate to 21%. There is no impact on deferred tax asset valuations related to this change due to the fact that the Company’s operations primarily reside in Canada.
DLT RESOLUTION INC.
(FORMERLY HEMCARE HEALTH SERVICES INC.)
Notes to Consolidated Financial Statements
December 31, 2018 and 2017
Note 13 – Discontinued Operations
Please see note 12 on the subsequent events regarding the items that happened after December 31, 2018. Due to the subsequent events the Company has completely phased out of A.J.D Data Services, Ltd. The assets and liabilities associated with the business are displayed as assets and liabilities held for sale as of December 31, 2018. They are listed as assets and liabilities held for sale due to the fact that the company divested itself of all investment in A.J.D. Data Services besides 10% interest on January 14, 2019 for a note receivable of $329,815 (CAD 450,000). As at December 31, 2018, value of the assets and liabilities has been presented at their net realizable value considering the value of note receivable. Additionally, the revenues and costs associated with this business are displayed as a loss from discontinued operations for the year ended December 31, 2018.
Total assets and liabilities included in discontinued operations were as follows:
|
Assets from Discontinued Operations:
|
|
December 31,
|
|
|
|
|
2018
|
|
|
Cash
|
|
|
30,954
|
|
|
Accounts receivable
|
|
|
166,134
|
|
|
Allowance for doubtful accounts
|
|
|
(141,280
|
)
|
|
Equipment, net of accumulated depreciation
|
|
|
17,678
|
|
|
Intangible assets, net of accumulated amortization
|
|
|
394,041
|
|
|
Goodwill
|
|
|
189,208
|
|
|
Total assets from discontinued operations
|
|
$
|
656,735
|
|
|
|
|
|
|
|
|
Liabilities from Discontinued Operations:
|
|
|
|
|
|
Accounts payable and accrued liabilities
|
|
|
144,185
|
|
|
Related party payables
|
|
|
1,942
|
|
|
Total liabilities from discontinued operations
|
|
$
|
146,127
|
|
The accounts payable and accrued liabilities of discontinued operations stated above include a HST / GST liability of $42,807 and payroll tax liability of $76,761 payable to Canada Revenue Agency. Further, the Company has not filed its HST / GST returns for the year ended December 31, 2018.
Net loss from discontinued operations for the year ended December 31, 2018 were comprised of the following components:
|
Net loss from discontinued operations
|
|
December 31,
|
|
|
|
|
2018
|
|
|
Net sales
|
|
$
|
554,351
|
|
|
Cost of sales
|
|
|
-
|
|
|
Gross profit
|
|
|
554,351
|
|
|
|
|
|
|
|
|
Operating expenses
|
|
|
|
|
|
General and administrative
|
|
|
700,472
|
|
|
Professional fees
|
|
|
74,494
|
|
|
Total operating expenses
|
|
|
774,966
|
|
|
|
|
|
|
|
|
Other income (expense)
|
|
|
|
|
|
Interest expense
|
|
|
(20
|
)
|
|
Interest income
|
|
|
370
|
|
|
Loss on discontinued operations
|
|
|
103,116
|
|
|
Total other income (expense)
|
|
|
103,466
|
|
|
|
|
|
|
|
|
Net loss from discontinued operations
|
|
$
|
(117,148
|
)
|
DLT RESOLUTION INC.
(FORMERLY HEMCARE HEALTH SERVICES INC.)
Notes to Consolidated Financial Statements
December 31, 2018 and 2017
Note 14 – Concentrations of revenue
The Company receives more than 23% of its revenue from five major customers. The Company is endeavoring to acquire more customers and has been successful in the current year doing so.
Note 15 – Commitments and contingencies
On August 4, 2018 DLT Resolution Inc. (“DLT”) was served with a statement of claim from a minority shareholder and former officer of its subsidiary A.J.D. Data Services Ltd. (“AJD”). This is an action commenced by Peter Darbyson (“Peter”) and Beverly Darbyson (“Beverly”) as against DLT and AJD. The action may be broken down into two broad components: (a) an oppression action in which Peter and Beverly seek damages in an undisclosed amount for defamation, damages for mental anxiety and distress and damages for fraud, conspiracy, conversion and unjust enrichment together with aggravated in punitive damages, also in an undisclosed amount. In addition, Peter and Beverly seek certain relief pursuant to Business Corporations Acts of both Ontario and Canada; (b) a wrongful dismissal action in which Peter (but not Beverly) seeks $650,000 damages for wrongful termination breach of contract and related matters.
Peter made an assignment in bankruptcy in January 2019. Thus, any claim by him was automatically stayed. Also, the oppression action arises as a result of an Agreement and Plan of Reorganization between the parties which contain a jurisdiction clause whereby any issues arising out of the agreement are to be governed by and in the jurisdiction of the state of West Virginia, USA. DLT and AJD have advised Peter and Beverly that they intend to move to have the oppression action stayed as a result of the jurisdiction clause. In response, Peter and Beverly initially advised that they were prepared to abandon the oppression portions of the claim and proceed only on Peter’s wrongful dismissal portion of the claim. Unfortunately – for them – this was prior to the bankruptcy of Peter. In the end result, Peter’s action in its entirety was stayed and Beverly’s action very well be stayed should she wish to proceed further.
As at September 05, 2019, the parties to the litigation have agreed to a settlement in principal.
On March 29, 2019, DLT Resolution Corp. and DLT Resolution Inc. was served with a Statement of Claim ats 300-306 Town Centre Boulevard Limited Partnership/Court File No. CV-19-00617228-000 (Toronto) for unpaid rent and lost revenue related to the premises. In this action, the Plaintiff has claimed damages against the Defendants DLT Resolution Corp. and DLT Resolution Inc. in the amount of $567,385.13 for an alleged breach of lease. The Plaintiff has claimed damages against the Defendant DLT Resolution Inc. in the amount of $567,385.13 for allegedly wrongfully inducing a breach of lease and tortious interference with contractual relations. The Plaintiff has further claimed damages against the Defendant DLT Resolution Inc. in the amount of $567,385.13 for allegedly oppressive conduct under the Ontario Business Corporations Act. The Plaintiff has further claimed compensation for its legal costs and for pre-judgment interest. The Company filed a statement of Defense citing, amongst other things, that it has never entered into any agreement with the landlord, nor guaranteed any such liability. The Defendants DLT Resolution Corp. and DLT Resolution Inc. intend to contest the claim vigorously. There is no intention to make a settlement offer nor have instructions been received to make a settlement offer at this juncture. Since the statement of defense was delivered on 16 May 2019, the Company had no further communication from counsel for the Plaintiff nor have any steps been taken to move the litigation forward. Although there can be no assurance of the Company’s ability to dismiss the claim, management feels the claim is without merit and is confident it will receive a ruling in its favor. There are legal fees in the amount of $5,287.24 that is yet to be paid with regards to this settlement which have been accrued and are in the accounts payable as of December 31, 2019. The bill will be paid within the month.
Note 16 – Intangible assets
The Company capitalizes software development costs in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 985-20. Non-compete, customer relationships, website and the domain and trade name are capitalized after useful lives based on prior experience in the telecom industry. Gross capitalized intangible assets totaled $549,226. Related amortization expense, included in general and administrative expenses, totaled $84,031 and $88,735 for the years ended December 31, 2019 and 2018, respectively.
Estimated future amortization expense totals as follows:
|
Year ended December 31,
|
|
|
|
|
2020
|
|
|
101,362
|
|
|
2021
|
|
|
64,751
|
|
|
2022
|
|
|
64,751
|
|
|
2023
|
|
|
64,751
|
|
|
2024
|
|
|
64,751
|
|
|
2025
|
|
|
16,275
|
|
|
Total
|
|
$
|
376,641
|
|
DLT RESOLUTION INC.
(FORMERLY HEMCARE HEALTH SERVICES INC.)
Notes to Consolidated Financial Statements
December 31, 2019 and 2018
Note 17 – Accrued liabilities and payables
During the year ended December 31, 2018, the Company has written back the Accounts payable of $9,072 due to statute of limitation. Further, accrued liabilities of the Company as at December 31, 2018 include a HST / GST liability of $10,402 relating to DLT Resolution Corp.
Note 18 – Subsequent events
On January 13, 2020 the Company issued stock to Christopher Wilson in a stock subscription agreement. The amount received was $25,000 for 31,250 common shares issued.
Acquisition of Union Strategies Inc.
On January 30, 2020, DLT Resolution Inc. (the “Company” or “we”) entered into transactions contemplated by the definitive share for share exchange agreement and plan of re-organization (the “Purchase Agreement”) by and among the Company, Union Strategies Inc. a corporation organized under the laws of Ontario (“Union Strategies”), the stockholders of Union Strategies Inc. (“Stockholders”) and other parties signatory thereto to acquire all the issued and outstanding capital stock of Union Strategies Inc. for 1,500,000 restricted common shares of DLT Resolution. The acquisition will result in Union Strategies becoming a wholly owned subsidiary of The Company.
In addition to the consideration on closing an additional 1,000,000 restricted common shares may potentially be issued upon meeting the following milestones:
|
·
|
Gross sales of Union Strategies to exceed CAD $3,100,000 with a minimum $75,000 in EBITDA for final 2020.
|
Share issuances will be issued under reliance of appropriate exemptions from registration with the Securities & Exchange Commission and will contain substantial resale restrictions.
The Stock Purchase Agreement contains customary representations, warranties and covenants by Union Strategies Inc., as well as customary indemnification provisions among the parties.
Acquisition of Union Strategies Inc.
On March 1, 2020, DLT Resolution Inc. (the “Company ” or “ we”) entered into and closed the transactions contemplated by the definitive share for share exchange agreement and plan of re-organization (the “Share Purchase Agreement”) discussed in the Company’s Form 8-K filed on January 30, 2020.
Summary of Acquisition of Union Strategies Inc.
On January 30, 2020, DLT Resolution Inc. (the “Company or “we ”) entered into transactions contemplated by the definitive share for share exchange agreement and plan of re-organization (the “Purchase Agreement”) by and among the Company, Union Strategies Inc. a corporation organized under the laws of Ontario (“Union Strategies”), the stockholders of Union Strategies Inc. (“Stockholders”) and other parties signatory thereto to acquire all the issued and outstanding capital stock of Union Strategies Inc. for 1,500,000 restricted common shares of DLT Resolution. The acquisition will result in Union Strategies becoming a wholly owned subsidiary of The Company.
In addition to the consideration on closing an additional 1,000,000 restricted common shares may potentially be issued upon meeting the following milestones:
|
•
|
Gross sales of Union Strategies to exceed CAD $3,100,000 with a minimum $75,000 in EBITDA for fiscal 2020.
|
Share issuances will be issued under reliance of appropriate exemptions from registration with the Securities & Exchange Commissions and will contain substantial resale restrictions.
The Stock Purchase Agreement contains customary representations, warranties and covenants by Union Strategies Inc., as well as customary indemnification provisions among the parties.
